TrxR1-IN-3

Overview

TrxR1-IN-3 is a selective TrxR1 inhibitor with an IC 50 of 1.19 μM. TrxR1-IN-3 increases intracellular reactive oxygen species ( ROS ) levels, induces endoplasmic reticulum (ER) stress, and activates Caspase -dependent Apoptosis . TrxR1-IN-3 exhibits anticancer activity against multiple breast cancer subtypes, including triple-negative breast cancer (TNBC). TrxR1-IN-3 can be used in breast cancer-related research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > TrxR | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > Caspase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-184328
• CAS No.: 3028398-90-2
• Molecular Formula: C36H52N2O6
• Molecular Weight: 608.81
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source